Eyeing contacts for the over-40 crowd
October 15th 2003Portland, OR-Now, more than ever, people with presbyopia are seeking to put aside their glasses to wear contact lenses. Aging baby boomers prefer to see and be seen without glasses. Career-oriented, they are involved in activities that require good vision not only at near and at distance, but also in the intermediate range.
Laser vision correction of presbyopia possible
October 15th 2003Halifax, Nova Scotia-In a small group of hyperopic patients, laser vision correction (LVC) with multifocal ablations seems to be an advantageous approach for improving both near and distance visual acuity, explained W. Bruce Jackson, MD, FRCSC, during the annual meeting of the Canadian Ophthalmologic Society here.
AAO makes case for OPT for Medicare patients
October 15th 2003Washington, DC-The Medicare Coverage Advisory Committee has voted overwhelmingly in favor of making ocular photodynamic therapy (PDT) with verteporfin (Visudyne, Novartis) available as a valid and important treatment for treating AMD in select patients with subfoveal choroidal neovascularization (CNV) with occult but no classic CNV.
IOL filters, protects against harmful UV, blue-light hazard
October 1st 2003London-Exposure of the retina to excessive blue light is hazardous to the pigment epithelial cells and may underlie the increase in the prevalence of age-related macular degeneration (AMD) in individuals in the eighth and ninth decades of life.
Novel piggybacking technique corrects postop ametropia
October 1st 2003Windsor, England-Piggybacking with the low-power meniscus MA60MA IOL (AcrySof, Alcon) is a useful technique for safely and accurately correcting post-cataract surgery ametropia, according to the results of a case series presented by Richard B. Packard, MD.
Hybrid design brings best of both worlds in IOL edges
October 1st 2003The Clariflex and Sensar AR40e IOLs (AMO) are physician-friendly implants that provide patients with unsurpassed optical performance because of their proprietary OptiEdge (AMO) design, agree cataract surgeons who favor the OptiEdge IOLs.
Iris-claw phakic IOL found to be safe for treating hyperopia
October 1st 2003Stanford, CA-The phase III trial of the iris-claw phakic IOL (Artisan, Ophtec) for the treatment of hyperopia is now 2 years post- launch, and the short- and long-term results from the interim analyses are very encouraging, said Edward E. Manche, MD.
Aspheric lens helps improve quality of vision
October 1st 2003Visual performance after cataract surgery is superior in eyes with the aspheric IOL implanted compared with other commonly used foldable implants, according to the results of a blinded, prospective, randomized study presented by Robert M. Kershner, MD, FACS.
Vision outcomes create optimistic expectation for spectacle independence
October 1st 2003Editor's Note: The CrystaLens was recommended for approval by the FDA's Ophthalmic Devices Advisory Panel in late May. The lens may be commercially available later this year or early 2004. Dr. Doane's presentation was given at the annual meeting of the American Society of Cataract and Refractive Surgery prior to the recommendation.
CIBA Vision echoes Pfizer's call for surgical business buyers
October 1st 2003Duluth, GA-Less than a month after Pfizer Inc. announced it would consider selling off the surgical business it acquired with its merger with Pharmacia Corp. (Ophthalmology Times, Sept. 1 issue, Page 3), another large manufacturer of ophthalmic surgical products has announced it is pondering selling the surgical segment of its business as well.
Water-mist product restores moisture to dry, irritated eyes
October 1st 2003Portland, OR-Nature's Tears EyeMist is a breakthrough product for the treatment of a variety of ocular irritations that delivers an ultra-fine mist of water to soothe and heal dry, irritated eyes, according to William D. Mathers, MD.
The Editors' Choices to feature year's top journal papers
October 1st 2003The American Academy of Ophthalmology (AAO) continues to work to provide the latest advances in ophthalmology through engaging new formats. At last year's annual meeting, we introduced a combined session with Ophthalmology, the American Journal of Ophthalmology, and Archives of Ophthalmology called The Editors' Choices.
Wavefront-oriented LASIK most useful as enhancement tool
October 1st 2003Alicante, Spain-Wavefront-oriented LASIK is a safe, effective, and predictable procedure for reducing higher-order aberrations and correcting residual refractive errors present after conventional LASIK, said Jorge L. Alio, MD, PhD.
Glaucoma with AV fistula requires multidisciplinary approach
October 1st 2003New York-Decisions on the management of glaucoma associated with arteriovenous (AV) fistulae requires close collaboration with neuroradiologists and other physician colleagues and careful discussion of observation versus intervention, said James C. Tsai, MD.
Contrast sensitivity improves in LASEK, LASIK patients
October 1st 2003Buenos Aires, Argentina-Contrast sensitivity, a more sensitive and accurate measure of functional vision than Snellen visual acuity, has been shown to improve after both LASIK and LASEK procedures in patients with low-to-moderate myopia, according to Carlos Argento, MD, and Mar?aJos? Cosentino, MD.
Hispanic sector sees high risk for open-angle glaucoma
October 1st 2003Los Angeles-A preliminary analysis of results from the Los Angeles Latino Eye Study (LALES) indicates open-angle glaucoma (OAG) has a high prevalence among older Latinos. In addition, the rate exceeds that found in white populations and is at least comparable with that seen among blacks, said Rohit Varma, MD, MPH.